Endocare to Enter Saudi Market Through Partnership with Riyadh’s The Clinics

Endocare, one of the UAE’s fast-growing obesity and metabolic healthcare providers, has announced plans to expand into Saudi Arabia through a strategic partnership with The Clinics, a leading multispecialty medical group based in Riyadh.

The partnership was confirmed through the signing of a Memorandum of Understanding (MoU) by Endocare Founder and CEO Leyla Azizova and The Clinics’ Medical Director and Chairman Dr Tariq Alshenaifi. The agreement reflects a shared goal to strengthen specialised obesity and metabolic care in the Kingdom.

Under the collaboration, Endocare will introduce its obesity and metabolic health services in Riyadh in the coming months. This marks the company’s first entry into the Saudi market, following its established operations in Dubai and Abu Dhabi.

Endocare is known for its integrated care model that combines medical treatment, advanced diagnostics, and lifestyle support in a single, coordinated programme. The approach focuses on long-term outcomes and addressing metabolic health challenges across the region.

Commenting on the expansion, Leyla Azizova said the move reflects growing regional demand for evidence-based metabolic care. She added that partnering with The Clinics will help Endocare launch in Riyadh with strong local expertise while maintaining its clinical standards.

Dr Tariq Alshenaifi said the partnership aligns with The Clinics’ commitment to specialised and structured healthcare services, noting that the collaboration will bring new treatment options to patients in Riyadh.

The partnership comes as Gulf countries place greater emphasis on metabolic health, chronic disease management, and sustainable healthcare models, positioning Endocare for further regional growth.